Delayed Gastric Emptying (Gastroparesis) Clinical Trials

• A Study of IC351 (tadalafil) for the treatment of diabetic patients with symptoms of dyspepsia (upset stomach) and gastroparesis (delayed gastric emptying).
  ClinicalTrials.gov Identifier: NCT00050609 - Completed
  Gastroparesis
  
• A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040
  ClinicalTrials.gov Identifier: NCT00562848 - Recruiting
  Enteral Feeding Intolerance; Gastroparesis; Diabetic Gastroparesis; Functional Dyspepsia
  
• Effects of Sitagliptin on Gastric Emptying in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00501657 - Not yet recruiting
  Gastroparesis; Diabetes Mellitus
  
• Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis
  ClinicalTrials.gov Identifier: NCT00390975 - Terminated
  Gastroparesis; Diabetes
  
• Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia
  ClinicalTrials.gov Identifier: NCT00370084 - Completed
  Gastroparesis
  
• Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis
  ClinicalTrials.gov Identifier: NCT00432835 - Active, not recruiting
  Gastroparesis
  
• Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis)
  ClinicalTrials.gov Identifier: NCT00157755 - Recruiting
  Gastroparesis
  
• Gastric Pacemaker Implantation for Gastroparesis
  ClinicalTrials.gov Identifier: NCT00568373 - Recruiting
  Gastroparesis
  
• Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
  ClinicalTrials.gov Identifier: NCT00492622 - Recruiting
  Gastroparesis; Gastroesophageal Reflux Disease
  
• Effect of Protein Composition on Gastric Emptying
  ClinicalTrials.gov Identifier: NCT00345566 - Not yet recruiting
  Cerebral Palsy; Gastric Dysmotility; Enteral Feeding
  
• Enterra Therapy Gastric Stimulation System
  ClinicalTrials.gov Identifier: NCT00556166 - Recruiting
  Gastroparesis
  
• Tricyclic Antidepressants (TCAs) on Gastric Emptying
  ClinicalTrials.gov Identifier: NCT00220844 - Recruiting
  Functional Dyspepsia
  
• Effect of Glutamine on Gastric Emptying and Length of Parenteral Nutrition in Premature Neonates
  ClinicalTrials.gov Identifier: NCT00213668 - Recruiting
  Enteral Feeding
  
• A Comparison of SmartPill Capsule with Scintigraphy for Determining Gastric Residence Time
  ClinicalTrials.gov Identifier: NCT00128284 - Recruiting
  Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases; Gastroparesis
  
• Domperidone for Gastroparesis in Solid Organ Transplantation
  ClinicalTrials.gov Identifier: NCT00552422 - Recruiting
  Gastroparesis; Gastroesophageal Reflux
  
• Placebo Controlled Trial of Botulinum Toxin for Gastroparesis
  ClinicalTrials.gov Identifier: NCT00372970 - Recruiting
  Gastroparesis
  
• Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.
  ClinicalTrials.gov Identifier: NCT00537719 - Not yet recruiting
  Healthy
  
• Effect of Electroacupuncture in Diabetic Patients With Gastroparesis
  ClinicalTrials.gov Identifier: NCT00227383 - Not yet recruiting
  Diabetes Mellitus; Gastroparesis
  
• Gastroparesis Registry
  ClinicalTrials.gov Identifier: NCT00398801 - Recruiting
  Gastroparesis
  
• Esomeprazole and Gastric Emptying of Beer
  ClinicalTrials.gov Identifier: NCT00472550 - Completed
  Gastroesophageal Reflux; Heartburn
  
• Safety and effectiveness of an investigational agent (GM-611) in patients with diabetic gastroparesis
  ClinicalTrials.gov Identifier: NCT00050882 - Completed
  Gastroparesis
  
• Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide
  ClinicalTrials.gov Identifier: NCT00489645 - Completed
  Type 1 Diabetes
  
• A Randomized, Open-Label, Two-Way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects with Diabetic Gastroparesis
  ClinicalTrials.gov Identifier: NCT00139893 - Completed
  Diabetic gastroparesis
  
• Moderate Alcohol Consumption, Glucose Metabolism and Gastric Emptying
  ClinicalTrials.gov Identifier: NCT00523861 - Completed
  Lean; Obese
  
• Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00004873 - Active, not recruiting
  stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer
  
• Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00074009 - Active, not recruiting
  recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
  
• Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00004103 - Active, not recruiting
  stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
  
• A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00123318 - Active, not recruiting
  Gastric Cancer
  
• Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00084604 - Active, not recruiting
  stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
  
• Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00002783 - Active, not recruiting
  stage III gastric cancer; stage II gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
  
• Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00003298 - Active, not recruiting
  stage III gastric cancer; stage IV gastric cancer; stage II gastric cancer; adenocarcinoma of the stomach
  
• Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
  ClinicalTrials.gov Identifier: NCT00152217 - Active, not recruiting
  Gastric Cancer
  
• Antineoplaston Therapy in Treating Patients With Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00003524 - Active, not recruiting
  stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
  
• Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
  ClinicalTrials.gov Identifier: NCT00464893 - Recruiting
  Gastric Cancer; Gastric Adenocarcinoma
  
• Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00004099 - Active, not recruiting
  stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer; intestinal adenocarcinoma of the stomach; ...
  
• Study of 5-Fluorouracil and Leucovorin and Intra-Abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00183911 - Recruiting
  Gastric Adenocarcinoma; Gastric Cancer
  
• Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)
  ClinicalTrials.gov Identifier: NCT00149266 - Active, not recruiting
  Gastric Neoplasm
  
• Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00103324 - Active, not recruiting
  recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; diffuse adenocarcinoma of the stomach; ...
  
• Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00320515 - Active, not recruiting
  Neoplasm, Gastric
  
• Testing for Bacterial Contamination During Gastric Surgeries
  ClinicalTrials.gov Identifier: NCT00417651 - Active, not recruiting
  Gastric Surgery
  
• Neoadjuvant Irinotecan and Cisplatin Followed By Surgical Resection in Treating Patients With Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00062374 - Active, not recruiting
  adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
  
• High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00002722 - Active, not recruiting
  childhood gastrointestinal cancer; stage III gastric cancer; stage IV gastric cancer
  
• Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00006389 - Active, not recruiting
  stage III gastric cancer; stage IV gastric cancer
  
• Cytokine Gene Polymorphisms in Gastric Diseases
  ClinicalTrials.gov Identifier: NCT00197470 - Recruiting
  Gastric Ulcer; Duodenal Ulcer; Gastric Cancer
  
• Bi-Weekly Docetaxel Plus 24-Hour Infusion of HDFL and for Inoperable Advanced or Metastatic Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00155883 - Recruiting
  Gastric Cancer
  
• Acupuncture for Diabetic Gastroparesis
  ClinicalTrials.gov Identifier: NCT00470795 - Not yet recruiting
  Diabetic Gastroparesis
  
• Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00005060 - Active, not recruiting
  stage II gastric cancer; stage III gastric cancer
  
• Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00103103 - Active, not recruiting
  recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
  
• A Phase III Trial of Laparoscopy-Assisted Distal Gastrectomy in Early Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00546468 - Active, not recruiting
  Gastric Cancer
  
• Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00006038 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage IV gastric cancer; ...
  
• Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
  ClinicalTrials.gov Identifier: NCT00061932 - Recruiting
  adenocarcinoma of the stomach; recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer
  
• Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
  ClinicalTrials.gov Identifier: NCT00075465 - Active, not recruiting
  adenocarcinoma of the stomach; stage III gastric cancer; stage IV gastric cancer
  
• Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Metastatic or Inoperable Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (Cancer)
  ClinicalTrials.gov Identifier: NCT00084617 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer
  
• YSPSL for Prevention of Delayed Graft Function Part A
  ClinicalTrials.gov Identifier: NCT00298181 - Active, not recruiting
  Delayed Graft Function
  
• S-1 and Cisplatin or Fluorouracil and Cisplatin in Treating Patients With Locally Advanced or Metastatic Gastric Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00128609 - Recruiting
  stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
  
• A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.
  ClinicalTrials.gov Identifier: NCT00380380 - Completed
  Diabetes Mellitus, Type 2
  
• A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00517283 - Completed
  Type 2 Diabetes Mellitus
  
• A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00351507 - Completed
  Diabetes Mellitus, Type 2
  
• GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma
  ClinicalTrials.gov Identifier: NCT00112099 - Recruiting
  Gastric Neoplasm
  
• Imatinib Mesylate in Treating Patients With Refractory Metastatic and/or Unresectable Stomach or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00068380 - Active, not recruiting
  recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; stage IV esophageal cancer; stage III esophageal cancer; ...
  
• Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00150670 - Active, not recruiting
  Gastric Cancer
  
• Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00002615 - Active, not recruiting
  stage II gastric cancer; stage III gastric cancer; adenocarcinoma of the stomach
  
• S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery For Locally Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00134095 - Recruiting
  adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
  
• MATRIX EG (Matuzumab Treatment With ECX in Esophago-Gastric Cancer)
  ClinicalTrials.gov Identifier: NCT00215644 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer
  
• Weekly DI for Inoperable Gastric Cancers After P-HDFL Regimen
  ClinicalTrials.gov Identifier: NCT00166881 - Recruiting
  Gastric Cancer
  
• Cyclooxygenase-2-Associated Factors and Gastric Carcinogenesis Mechanisms-Clinical Association and Genomic Investigation
  ClinicalTrials.gov Identifier: NCT00172861 - Recruiting
  Gastric Cancer
  
• Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00005876 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
  
• Effect of Procrit(Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00425126 - Recruiting
  Delayed Graft Function
  
• Phase 1/2 study of S-1 and cisplatin in advanced gastric cancer
  ClinicalTrials.gov Identifier: NCT00072787 - Active, not recruiting
  Gastric Cancer
  
• Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00183872 - Recruiting
  Gastric Cancer; Esophageal Neoplasms
  
• Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00004236 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
  
• A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of UFT Compared with Surgery Alone (NSAS-GC)
  ClinicalTrials.gov Identifier: NCT00152243 - Active, not recruiting
  Gastric Cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
  ClinicalTrials.gov Identifier: NCT00005607 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers
  ClinicalTrials.gov Identifier: NCT00527787 - Recruiting
  Gastric Ulcer
  
• BrUOG-EG-203 Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00439608 - Active, not recruiting
  Esophageal; Gastroesophageal; Gastric Cancer
  
• Biological Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00005956 - Active, not recruiting
  stage III gastric cancer; stage IIIB breast cancer; stage II gastric cancer; stage IIIA breast cancer; stage III ovarian epithelial cancer; ...
  
• Avastin and Taxotere for Esophagogastric Cancer
  ClinicalTrials.gov Identifier: NCT00137813 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer
  
• Irinotecan in Treating Patients With Esophageal or Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00003748 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; ...
  
• Randomized Phase III Study of 5-FU Versus MTX+5-FU in Gastric Cancer with Peritoneal Metastasis (JCOG0106-MF, MF/5FU)
  ClinicalTrials.gov Identifier: NCT00149201 - Active, not recruiting
  Gastric Cancer with Peritoneal Metastasis
  
• Chlorambucil Compared With No Further Therapy Following Anti- Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
  ClinicalTrials.gov Identifier: NCT00003617 - Active, not recruiting
  stage I gastric cancer
  
• Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002883 - Active, not recruiting
  stage I gastric cancer; stage II gastric cancer; stage I esophageal cancer; stage II esophageal cancer; adenocarcinoma of the stomach; ...
  
• Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)
  ClinicalTrials.gov Identifier: NCT00407186 - Recruiting
  Gastric Cancer
  
• Safety Study of 2nd Generation Anti-CEA Designer T Cells to Treat Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00429078 - Recruiting
  Gastric Cancer
  
• T900607 in Treating Patients With Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00054249 - Active, not recruiting
  recurrent gastric cancer
  
• Phase III Trial of Neoadjuvant TS-1 and CDDP for Type 4 and Large Type 3 Gastric Cancer.JCOG0501
  ClinicalTrials.gov Identifier: NCT00252161 - Recruiting
  Gastric Neoplasm
  
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00448682 - Recruiting
  Gastric Cancer
  
• Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
  ClinicalTrials.gov Identifier: NCT00209729 - Recruiting
  Gastric Cancer
  
• Neo-Adjuvant Chemotherapy in Locally Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00414271 - Recruiting
  Stage T3-4NxM0 Gastric Cancer
  
• A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.
  ClinicalTrials.gov Identifier: NCT00436241 - Recruiting
  Gastric Cancer
  
• Comparison of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Prospective Randomized Trial
  ClinicalTrials.gov Identifier: NCT00452751 - Recruiting
  Gastric Cancer
  
• A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.
  ClinicalTrials.gov Identifier: NCT00454636 - Recruiting
  Gastric Cancer
  
• Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00054457 - Active, not recruiting
  adenocarcinoma of the stomach; Adenocarcinoma of the Esophagus; stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; ...
  
• Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00210184 - Recruiting
  Gastric Cancer
  
• Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00323830 - Recruiting
  Gastric Cancer; Surgery
  
• Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding
  ClinicalTrials.gov Identifier: NCT00567216 - Recruiting
  Liver Cirrhosis and Hepatoma.; Gastric Variceal Bleeding
  
• Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00020787 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00415168 - Recruiting
  Gastric Cancer
  
• A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00533533 - Recruiting
  Gastric Cancer
  
• Synchronization and Desynchronization Between Circadian Rhythms in Patients With Delayed Sleep Phase Syndrome (DSPS)
  ClinicalTrials.gov Identifier: NCT00282061 - Recruiting
  Delayed Sleep Phase Syndrome
  
• Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-Induced Gastric Ulcer
  ClinicalTrials.gov Identifier: NCT00401752 - Recruiting
  Gastric Ulcer